Posted in | News | Semiconductor

Intel Invests into Ovonyx, Semiconductor Memory Technology

Ovonyx has announced that Intel Capital has made an additional investment in the company. Financial terms were not disclosed.

Ovonyx memory technology uses a reversible phase-change memory process that has been previously commercialized worldwide in rewritable CD and DVD optical memory disks. The Ovonyx array-addressed semiconductor memory technology can be used in many applications benefiting from non-volatile low power memory such as mobile computing, communications, and information appliances, as well as embedded applications in many product areas such as microcontrollers and reconfigurable MOS logic.

In February 2000, Ovonyx announced that Intel Capital had made an investment in the company and that Ovonyx had licensed its phase-change memory technology to Intel. The two companies have been working together since then to develop and demonstrate the feasibility of high-density, non-volatile memory based on the technology.

"The Investment will be used to further the strategic goals of Ovonyx, principally by supporting ongoing development activities, and we look forward to continuing our joint development program with Intel," said Tyler Lowrey, President & CEO of Ovonyx.

"Intel continues to explore and invest in a wide variety of new memory technologies," said Stefan K. Lai, Intel Corporation Vice President and Director of California Technology Manufacturing. "Intel's incremental investment in Ovonyx reflects our continued interest in exploring the potential of the technology as a future nonvolatile memory alternative."

http://www.ovonyx.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.